![ALS Drug Withdrawn from Canada and U.S. Markets Following Clinical Trial Failure](http://spanglish.ca/cdn/shop/articles/489c24b3-0056-46c3-a5e2-0ef12a71759e.png?v=1712235634&width=1100)
ALS Drug Withdrawn from Canada and U.S. Markets Following Clinical Trial Failure
Share
![SpanglishNewsNetwork](https://files.canvas.switchboard.ai/90937fbf-556c-48f2-bf91-38b8fd2c4c62/489c24b3-0056-46c3-a5e2-0ef12a71759e.png)
En Español: 📰 ¡Últimas noticias! 🚨 Amylyx Pharmaceuticals retira su medicamento para ELA del mercado en Estados Unidos y Canadá. 😱🌎 Esta lamentable decisión se produce luego de que el tratamiento no obtuviera resultados positivos en un crucial ensayo de fase avanzada. 😔❌ #AmylyxPharmaceuticals #ELA #RetiroDeMedicamentos #FracasoEnElEnsayoClínico #Noticias
This headline news segment is brought to you by Spanglish News and BHIVE Labs. If you appreciate our headline summaries, we invite you to explore our collection below. Your purchase supports our mission and makes a real impact.
Try BHIVE Nectar and publish your own news on whatever topic/language you choose. Stay top of mind with your network. Go to Nectar.Social for more info or use QR code to access app. BHIVE is a Canadian owned and operated company.